me likey...
Research, Development and Regulatory
In addition to the FDA clinical trials, PainChek has continued to invest in the development of the core
technology to expand capability into the desktop and embedded platforms for virtual and remote
telehealth pain assessment platforms.
- Forums
- ASX - By Stock
- PCK
- Ann: Half Yearly Report and Accounts
PCK
painchek ltd
Add to My Watchlist
0.00%
!
4.0¢

Ann: Half Yearly Report and Accounts, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.68M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 142370 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 895239 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 142370 | 0.038 |
1 | 10628 | 0.037 |
1 | 55277 | 0.036 |
4 | 509071 | 0.035 |
3 | 158852 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 895239 | 2 |
0.045 | 88210 | 2 |
0.048 | 150000 | 1 |
0.049 | 11907 | 1 |
0.050 | 728780 | 4 |
Last trade - 07.10am 25/07/2025 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |
Day chart unavailable
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online